2024 France Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

August 2024 | | ID: 25C78500B89BEN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. ;Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ;Test volume and sales forecasts for 40 tumor markers performed in French hospitals.;Current instrumentation technologies and feature comparison of leading analyzers.;Sales and market shares of leading suppliers. ;Emerging diagnostic technologies and their potential market applications. ;Product development opportunities. ;Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. ;Business opportunities and strategic recommendations for suppliers.Contains 533 pages and 43 tables

Contents

Introduction
Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology

1. BREST CANCER

2. LUNG CANCER

3. COLON AND RECTUM CANCER

4. PROSTATE CANCER

5. STOMACH CANCER

6. LEUKEMIA

7. LYMPHOMA

8. ORAL CANCER

9. SKIN CANCER

10. UTERINE CANCER

11. OVARIAN CANCER

12. BLADDER CANCER

B. Major Current And Emerging Cancer Diagnostic Tests

1. INTRODUCTION

2. TUMOR MARKER CLASSIFICATION

3. ACTH

4. ALPHA-FETOPROTEIN (AFP)

5. BETA-2 MICROGLOBULIN

6. CA 15-3/27.29

7. CA 19-9

8. CA-125

9. CALCITONIN

10. CARCINOEMBRIONIC ANTIGEN (CEA)

11. ESTROGEN AND PROGESTERONE RECEPTORS

12. FERRITIN

13. GASTRIN

14. HUMAN CHORIONIC GONADOTROPIN (HCG)

15. INSULIN



16. NSE

17. OCCULT BLOOD

18. PAP SMEAR/HPV

19. PROSTATIC ACID PHOSPHATASE (PAP)

20. PROSTATE-SPECIFIC ANTIGEN (PSA)

21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)

22. T AND B LYMPHOCYTES

23. TDT

24. THYROGLOBULIN

25. TISSUE POLYPEPTIDE ANTIGEN (TPA)

26. BIOCHEMICAL TUMOR MARKERS

- ADA
- B-Protein
- PNP
- 5'-Nucleotidase

27. ONCOGENES

- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP-17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src